骨坏死与骨关节炎患者初次全髋置换五年假体生存率与并发症比较
基于全国数据库2010至2021年首次全髋置换、随访至少5年的数据,将43,893例无特定危险因素的骨坏死患者按年龄、性别和合并症1:5匹配218,935例骨关节炎患者。骨坏死组脱位、无菌性松动、假体周围感染和全因翻修风险均高于骨关节炎组,尤其50岁及以上人群。
要点
- 骨坏死患者全髋置换后2年和5年脱位风险均高于骨关节炎患者,且不受年龄影响
- 50岁及以上骨坏死患者5年无菌性松动和假体周围骨折风险增加
- 骨坏死患者2年和5年假体周围感染及全因翻修风险均升高
核心结论
- 无特定危险因素的骨坏死患者全髋置换后5年脱位、无菌性松动、假体周围感染和翻修风险高于骨关节炎患者,50岁以上者更明显。
研究设计与样本
- 回顾性队列研究,使用2010至2021年全国数据库,纳入初次全髋置换且随访至少5年的患者。
- 排除镰状细胞病、白血病、活动性使用皮质类固醇、人类免疫缺陷病毒和遗传性疾病。
- 43,893例骨坏死患者按年龄、性别和合并症1:5匹配218,935例骨关节炎患者,两组约85%年龄至少50岁。
- 按年龄(小于50岁和至少50岁)分层分析2年和5年假体并发症,采用多因素logistic回归计算比值比(OR),显著性定义为P < 0.003。
主要发现
- 骨坏死与骨关节炎相比,2年脱位OR 1.59至1.67,5年脱位OR 1.52至1.60,不受年龄影响。
- 50岁及以上骨坏死患者2年无菌性松动OR 1.60,5年OR 1.46;5年假体周围骨折OR 1.41。
- 骨坏死患者2年假体周围感染OR 1.41,5年OR 1.43;2年全因翻修OR 1.68,5年OR 1.55。
临床怎么用
- 对骨坏死患者行全髋置换时应充分告知其脱位、无菌性松动、假体周围感染和翻修风险高于骨关节炎患者。
- 50岁以上骨坏死患者术后需加强随访,关注假体周围骨折和无菌性松动的迹象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Survivorship of total hip arthroplasty (THA) may differ in patients who have osteonecrosis (ON) or osteoarthritis (OA), but this may reflect risk factors known to lead to poor results. This study compared two- and 5-year implant complications, including (1) mechanical complications (dislocation, aseptic loosening, and periprosthetic fracture), (2) periprosthetic joint infections (PJIs), and (3) all-cause revisions, after THA for ON without specified risk factors versus OA. METHODS: A nationwide database was reviewed from 2010 to 2021 for primary THA with a minimum 5-year follow-up. Exclusions were sickle cell disease, leukemia, active corticosteroid use, human immunodeficiency virus, and genetic diseases. A total of 43,893 patients who had ON were 1:5 ratio-matched to 218,935 patients who had OA by age, sex, and comorbidities, with approximately 85% of each cohort being at least 50 years of age. Outcomes were two- and 5-year implant complications analyzed in cohorts dichotomized by age (less than 50 and at least 50 years). Multivariable logistic regressions computed odds ratios (ORs), with significance defined as P < 0.003. RESULTS: Osteonecrosis was associated with increased odds of dislocation at two (OR 1.59 to 1.67) and 5 years (OR 1.52 to 1.60) versus OA, regardless of age. In patients aged 50 years and older, ON increased odds of aseptic loosening at two (OR 1.60) and five (OR 1.46) years and periprosthetic fracture at five years (OR 1.41). There was an increased PJI risk at two (OR 1.41) and five (OR 1.43) years, and all-cause revision risk was higher at two (OR 1.68) and five (OR 1.55) years. CONCLUSIONS: Patients undergoing THA for ON, particularly those older than 50 years, experienced greater odds of dislocation, aseptic loosening, PJI, and revision at five years compared with OA. These data inform expectations for longitudinal implant outcomes by indication. LEVEL OF EVIDENCE: III.
引用
- Gordon AM, Nian PP, Smitterberg CW, et al. Implant Survivorships and Complications Among Patients Undergoing Primary Total Hip Arthroplasty for Osteonecrosis Versus Osteoarthritis: Five-Year Minimum Follow-up. J Arthroplasty. 2026. PMID: 41967985. doi:10.1016/j.arth.2026.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。